Roujeau JC - Search Results

1

Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.

Nassif A, Bensussan A, Dorothée G, Mami-Chouaib F, Bachot N, Bagot M, Boumsell L, Roujeau JC. Nassif A, et al. Among authors: roujeau jc. J Invest Dermatol. 2002 Apr;118(4):728-33. doi: 10.1046/j.1523-1747.2002.01622.x. J Invest Dermatol. 2002. PMID: 11918724 Free article.

2

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.

Bachot N, Revuz J, Roujeau JC. Bachot N, et al. Among authors: roujeau jc. Arch Dermatol. 2003 Jan;139(1):33-6. doi: 10.1001/archderm.139.1.33. Arch Dermatol. 2003. PMID: 12533161 Clinical Trial.

3

Differential diagnosis of severe cutaneous drug eruptions.

Bachot N, Roujeau JC. Bachot N, et al. Among authors: roujeau jc. Am J Clin Dermatol. 2003;4(8):561-72. doi: 10.2165/00128071-200304080-00006. Am J Clin Dermatol. 2003. PMID: 12862499 Review.

4

Intravenous immunoglobulins in the treatment of severe drug eruptions.

Bachot N, Roujeau JC. Bachot N, et al. Among authors: roujeau jc. Curr Opin Allergy Clin Immunol. 2003 Aug;3(4):269-74. doi: 10.1097/00130832-200308000-00006. Curr Opin Allergy Clin Immunol. 2003. PMID: 12865770 Review.

5

Evaluation of the potential role of cytokines in toxic epidermal necrolysis.

Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, Boumsell L, Bensussan A, Roujeau JC. Nassif A, et al. Among authors: roujeau jc. J Invest Dermatol. 2004 Nov;123(5):850-5. doi: 10.1111/j.0022-202X.2004.23439.x. J Invest Dermatol. 2004. PMID: 15482470 Free article.

6

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC. Nassif A, et al. Among authors: roujeau jc. J Allergy Clin Immunol. 2004 Nov;114(5):1209-15. doi: 10.1016/j.jaci.2004.07.047. J Allergy Clin Immunol. 2004. PMID: 15536433

7

[Epidermal necrolysis: mechanisms of keratinocyte apoptosis].

Roujeau JC, Gélard K, Bensussan A. Roujeau JC, et al. Med Sci (Paris). 2006 Feb;22(2):188-91. doi: 10.1051/medsci/2006222188. Med Sci (Paris). 2006. PMID: 16457761 Free article. Review. French.

8

Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.

de Araujo E, Dessirier V, Laprée G, Valeyrie-Allanore L, Ortonne N, Stathopoulos EN, Bagot M, Bensussan A, Mockenhaupt M, Roujeau JC, Tsapis A. de Araujo E, et al. Among authors: roujeau jc. Exp Dermatol. 2011 Feb;20(2):107-12. doi: 10.1111/j.1600-0625.2010.01176.x. Exp Dermatol. 2011. PMID: 21255088 Free article.

9

Impaired antigen presentation in toxic epidermal necrolysis.

Bagot M, Charue D, Heslan M, Wechsler J, Roujeau JC, Revuz J. Bagot M, et al. Among authors: roujeau jc. Arch Dermatol. 1993 Jun;129(6):721-7. Arch Dermatol. 1993. PMID: 8507074

10

Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors.

Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault-Villada I, Bensussan A, Roujeau JC. Le Cleach L, et al. Among authors: roujeau jc. Clin Exp Immunol. 2000 Jan;119(1):225-30. doi: 10.1046/j.1365-2249.2000.01119.x. Clin Exp Immunol. 2000. PMID: 10606987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters